Passage of mannitol into the brain around gliomas: A potential cause of rebound phenomenon: A study on 21 patients

Journal of Neurosurgical Sciences

Volumn 50, Issue 3, 2006, Pages 63-66

  Palma, L ^a,b   Bruni, G ^a   Fiaschi, A I ^a   Mariottini, A ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Gliomas; Mannitol; Rebound Phenomenon

Indexed keywords

MANNITOL;

ADULT; AGED; ARTICLE; BRAIN EDEMA; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOTOMY; DRUG ACTIVITY; DRUG BLOOD LEVEL; ENZYME ASSAY; GLIOMA; HUMAN; MENINGIOMA; METASTASIS; REBOUND; TUMOR CELL; WHITE MATTER;

ADULT; AGED; BLOOD; BLOOD-BRAIN BARRIER; BRAIN; BRAIN EDEMA; BRAIN NEOPLASMS; DIURETICS, OSMOTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR FLUID; FEMALE; GLIOMA; HUMANS; INTRACRANIAL HYPERTENSION; MALE; MANNITOL; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NERVE FIBERS, MYELINATED; WATER-ELECTROLYTE BALANCE;

EID: 33751531153     PISSN: 00264881     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Shenkin HA, Goluboff B, Haft H. The use of mannitol for reduction of intracranial pressure in intracranial surgery. J Neurosurg 1962;19:897-901.
2. Cantore GP, Guidetti B, Virno M. Oral glycerol for the reduction of intracranial ressue. J Neurosurg 1964;21:278-83.
3. Javid M, Gilboe D, Cesario T. The rebound phenomenon and hypertonic solutions. J Neurosurg 1964;21:1059-66.
4. Guisado R, Tourtellotte WW, Arieff AI. Rebound phenomenon complicating cerebral dehydration with glycerol. J Neurosurg 1975;44:226-8.
5. Anderson P, Borèus L, Gordon E. Use of mannitol during neurosurgery: interpatient variability in the plasma and CSF levels. Eur J Clin Pharmacol 1988;35:643-9.
6. Node Y, Nakazawa S. Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon. Adv Neurol 1990;52:359-63.
7. Kaufmann GE, Cardoso ER. Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg 1992;77:584-9.
8. Kofke WA. Mannitol: Potential for rebound intracranial hypertension? J Neurosurg Anesthesiol 1993;5:1-3.
9. McManus ML, Soriano SG. Rebound swelling of astroglial cells exposed to hypertonic mannitol. Anesthestology 1998;88:1586-91.
10. Paczynski RP. Osmotherapy: basic concepts and controversies. Crit Care Clin 1997;13:105-29.
11. Nau R. Osmotherapy for elevated intracranial pressure: a critical reappraisal. Clin Pharmacokinet 2000;38:23-40.
12. Von Berenberg P, Unterberg A, Schneider GH, Lanksch WR. Treatment of Traumatic Brain Edema by Multiple Doses of Mannitol. Acta Neurochir Suppl 1994;60:531-3.
13. Rudehill A, Gordon E, Ohman G. Pharmacokinetics and effect of mannitol on hemodynamics, blood and cerebrospinal fluid electrolytes, and osmolality during intracranial surgery. J Neurosurg Anesthesiol 1993;5:4-12.
14. Polderman KH, Van De Kraats G, Dixon JM, Vandertop WP, Grirbes ARJ. Increases in spinal fluid osmolarity induced by mannitol. Crit Care Med 2003;31:584-90.
15. Wise BL, Perkins RK, Steverson E. Penetraction of C14-labelled mannitol from serum into cerebrospinal fluid and brain. Exp Neurol 1964;10:264-70.
16. Blomquist CH, Snyder BD, Niehaus WG. Improved enzymatic method for determining mannitol and its application to dog serum after mannitol infusion. J Clin Chem Clin Biochem 1981;19;139-43.
17. Shalmon E, Reichenthal E, Kaspi T. Transient effect of mannitol on cerebral blood flow following brain injury. Acta Neurochir Suppl 1990;51:116-7.
18. Garcia-Sola R, Pulido P, Capilla P. The immediate and long-term effects of mannitol and glycerol: a comparative experimental study. Acta Neurochir Vien 1991;109:114-21.
19. Weed LH, McKibben PS. Experimental alteration of brain bulk. Am J Physiol 1919;48:531-55.
20. Levin AB, Duff TA, Javid MJ. Treatment of increased intracranial pressure a comparison of different hyperosmotic agents and the use of thiopental. Neurosurgery 1979;5:570-4.
21. Nau R, Prins FJ, Kolenda H. Temporary reversal of serum to cerebrospinal fluid glycerol concentration gradient after intravenous infusion of glycerol. Eur J Clin Pharmacol 1992;42:181-5.
22. Nasrallah SM, and Iser FL. Mannitol absorption and metabolism in man. Am J Med Sci 1967;258:80-8.
23. Chan PH, and Fishman RA. Elevation of rat brain aminoacids, ammonia, and idiogenic osmoles induced by hyperhosmolality, Brain Res 1978;161:293-301.
24. Waterhouse JM, Coxon RV. The entry of glycerol into brain tissue. J Neurol Sci 1970;10:305-11.
25. Konig K, Rickels E, Heissler HE, Zumkeller M, Samii M. Artificial elevation of brain tissue glycerol by administration of a glycerol-containing agent. Case report. J Neurosurg 2001;94:621-3.
26. Levin VA, Freeman-Dove M, Landahl HD. Permeability characteristics of brain adjacent to tumors in rats. Arch Neurol 1975;32:785-91.
27. Hirano A, and Matsui T. Vascular structures in brain tumors. Hum Pathol 1975;6:611-21.
28. Schneider SW, Ludwig T, Tatenhorst L, Braume S, Oberteithner H, Senner V et al. Glioblastoma cells release factors that disrupt blood-brain barrier features. Acta Neuropathol 2004;107:272-6.
29. Straathof CSM, Van Den Bent MJ, Ma J, Schmitz PIM, Kros JM, Stoter G et al. The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor. Journal of Neuro-Oncology 1998;37:1-8.